跳至主要内容
临床试验/NL-OMON49238
NL-OMON49238已完成4 期

Reducing hospital admission of elderly in SARS-CoV-2 pandemic via the induction of trained immunity by bacillus Calmette-Guérin vaccination, a randomized controlled trial. - BCG-CORONA-ELDERLY

Radboud Universitair Medisch Centrum0 个研究点目标入组 2,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
2,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet the
  • following criteria:
  • Adult (>= 60 years)
  • Written informed consent

排除标准

  • Fever (>38 ºC) within the past 24 hours
  • Suspicion of current active viral or bacterial infection
  • - Vaccination within 3 months of start studyperiod
  • Severely immunocompromised subjects. This exclusion category comprises: a)
  • subjects with known infection by the human immunodeficiency virus (HIV-1); b)
  • neutropenic subjects with less than 500 neutrophils/mm3; c) subjects with solid
  • organ transplantation; d) subjects with bone marrow transplantation; e)
  • subjects under chemotherapy; f) subjects with primary immunodeficiency; g)
  • severe lymphopenia with less than 400 lymphocytes/mm3; h) treatment with any
  • immunosuppressant drugs such as anti-cytokine therapies, and treatment with
  • oral or intravenous steroids defined as daily doses of 10mg prednisone or
  • equivalent for longer than 3 months, or probable use of oral or intravenous
  • steroids in the following four weeks
  • Active solid or non-solid malignancy or lymphoma within the prior two years
  • Active participation in another research study that involves BCG
  • administration

研究者

相似试验